FMR CORP 13D and 13G filings for AlloVir, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 08:35 am Sale |
2024-02-08 | 13G | AlloVir, Inc. ALVR |
FMR CORP | 247,512 4.990% |
-58,852 (-19.21%) |
Filing |
| 2023-02-09 08:23 am Sale |
2023-02-09 | 13G | AlloVir, Inc. ALVR |
FMR CORP | 306,364 7.563% |
-14,552 (-4.53%) |
Filing |
| 2022-02-09 09:09 am Purchase |
2022-02-08 | 13G | AlloVir, Inc. ALVR |
FMR CORP | 320,916 11.330% |
8,849 (+2.84%) |
Filing |
| 2021-02-08 10:15 am Purchase |
2021-02-05 | 13G | AlloVir, Inc. ALVR |
FMR CORP | 312,067 11.024% |
42,870 (+15.93%) |
Filing |
| 2020-08-10 09:25 am Purchase |
2020-08-07 | 13G | AlloVir, Inc. ALVR |
FMR CORP | 269,197 10.121% |
269,197 (New Position) |
Filing |